Genenta Science S.p.A.
GNTA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001838716
No open-market purchases or sales by Genenta Science S.p.A. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.33M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Genenta Science S.p.A. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 3 | 3 | 0 |
| Shares | 47.4K | 3.71K | −43.7K (−92.2%) |
| Value | $332.0K | $27.0K | −$305.0K (−91.9%) |
New holders (1)
Institutions that held Genenta Science S.p.A. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Morgan Stanley | 500 | $4.00K | 0.00% |
Sold out (1)
Institutions that held Genenta Science S.p.A. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Algebris (UK) Ltd | 45,000 | $315.0K |